This is a prospective, multi-center, post market registry study designed to evaluate the safety and efficacy of treatment with Balt coils in patients with chronic subdural hematoma (cSDH).
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in hematoma volume
Timeframe: 180 days
Change in maximal thickness
Timeframe: 180 days
Change in midline shift
Timeframe: 180 days
Number of periprocedural major disabling stroke or any death
Timeframe: 30 days
Number of participants with symptomatic recurrence progression requiring retreatment
Timeframe: 180 days